Advanced search

Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
SCADDING, GK, AJ TASMAN, M MURRIETA-AGUTTES, and Claus Bachert. 1999. “Mizolastine Is Effective and Well Tolerated in Long-term Treatment of Perennial Allergic Rhinoconjunctivitis.” Journal of International Medical Research 27 (6): 273–285.
APA
SCADDING, G., TASMAN, A., MURRIETA-AGUTTES, M., & Bachert, C. (1999). Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 27(6), 273–285.
Vancouver
1.
SCADDING G, TASMAN A, MURRIETA-AGUTTES M, Bachert C. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 1999;27(6):273–85.
MLA
SCADDING, GK, AJ TASMAN, M MURRIETA-AGUTTES, et al. “Mizolastine Is Effective and Well Tolerated in Long-term Treatment of Perennial Allergic Rhinoconjunctivitis.” JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 27.6 (1999): 273–285. Print.
@article{170722,
  author       = {SCADDING, GK and TASMAN, AJ and MURRIETA-AGUTTES, M and Bachert, Claus},
  issn         = {0300-0605},
  journal      = {JOURNAL OF INTERNATIONAL MEDICAL RESEARCH},
  language     = {eng},
  number       = {6},
  pages        = {273--285},
  title        = {Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis.},
  volume       = {27},
  year         = {1999},
}

Web of Science
Times cited: